Literature DB >> 17987798

Microsatellite instability (MSI) and MLH1 and MSH2 protein expression analysis in postmenopausal women with sporadic endometrial cancer.

A Sobczuk1, H Romanowicz-Makowska, B Smolarz, T Pertynski.   

Abstract

Microsatellite instability (MSI) seems to be important for the development of various human cancers including sporadic endometrial cancer. The aim of this study was evaluation of microsatellite instability in 60 postmenopausal women with endometrial cancer in DNA samples obtained from cancer tissue and blood of the same patients. Control DNA was obtained from normal endometrial tissue (n = 70). MSI was studied at five loci containing single- or dinucleotide repeat sequences and mapping to different chromosomal locations: BAT-25 (at locus 4q12), BAT-26 (2p16), D2S123 (2p16-p21), D5S346 (5q21-q22) and D17S250 (171q11.2-q12). No differences in the MSI frequencies between blood and cancer tissue obtained from patients were detected. The microsatellite instability status was significantly higher in endometrial cancer tissue [21/60 (35%)] compared to control [8/70 (11%)] (p < 0.05). There were significant differences between MSI presence in the subgroups assigned to the histological grades (p < 0.05). The lack of association between MLH1 and MSH2 protein expression and MSI in endometrial cancer samples was observed. The results suggest that the microsatellite instability seems to be important in the development of sporadic endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987798

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  2 in total

1.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Authors:  Daniel D Buchanan; Yen Y Tan; Michael D Walsh; Mark Clendenning; Alexander M Metcalf; Kaltin Ferguson; Sven T Arnold; Bryony A Thompson; Felicity A Lose; Michael T Parsons; Rhiannon J Walters; Sally-Ann Pearson; Margaret Cummings; Martin K Oehler; Penelope B Blomfield; Michael A Quinn; Judy A Kirk; Colin J Stewart; Andreas Obermair; Joanne P Young; Penelope M Webb; Amanda B Spurdle
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

2.  Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.

Authors:  Vittoria Stigliano; Daniela Assisi; Maurizio Cosimelli; Raffaele Palmirotta; Diana Giannarelli; Marcella Mottolese; Lupe Sanchez Mete; Raffaello Mancini; Vincenzo Casale
Journal:  J Exp Clin Cancer Res       Date:  2008-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.